Boston Harbor Angels Facts
We have over 70 active members. Since 2004 we have made investments in over 70 start-up companies in medical devices, IT, consumer products, business products, specialty materials, Internet, aviation, etc.
Boston Harbor Angels members are early investors in SmartCells, which was bought by Merck for $500 Million in 2010, as well as in Carbonite, which had a successful IPO in August 2011.
Our members participated in all rounds of financing for SmartCells and three rounds of financing for Carbonite.
Boston Harbor Angels members are early investors in JB Therapeutics. Corbus Pharmaceuticals, formerly JB Therapeutics, successfully completed a $10.3 million private placement equity financing in June of 2014.
Corbus Pharmaceuticals, initiated trading on the Over-the-Counter Markets (OTCQB) under the ticker symbol “CRBP” in October 2014.
One of our companies received the prestigious Silvertip Luis Villalobos Award, and was recognized as one of the most impressive companies at the 2011 National Angel Capital Association Summit.